1-3 of 3
Brian S. Garrison
Close
Sort by
Journal Articles

Calibrated Release IL15 Bivalent CD33 and/or FLT3 and NOT Emcn Logic Gated Gene Circuit CAR-NK Cell Therapy (SENTI-202) in Venetoclax Resistant Patient Derived Xenograft Acute Myeloid Leukemia Models

Muharrem Muftuoglu, Mahesh Basyal, Li Li, Jiangxing Lv, Lauren B. Ostermann, Ran Zhao, Baozhen Ke, Hiroki Akiyama, Po Yee Mak, Bing Z. Carter, Han Deng, Yongshuai Li, Brian S. Garrison, Kanya L. Rajangam, Michael Andreeff
Journal: Blood
Blood (2023) 142 (Supplement 1): 4831.
https://doi.org/10.1182/blood-2023-191127
Published: 2023
Journal Articles

FLT3 OR CD33 NOT EMCN Logic Gated CAR-NK Cell Therapy (SENTI-202) for Precise Targeting of AML

Brian S. Garrison, Han Deng, Gozde Yucel, Nicholas W. Frankel, Marcela Guzman-Ayala, Russell Gordley, Michelle Hung, Derrick Lee, Marcus Gainer, Kathryn Loving, Jenny Chien, Tiffany Pan, Wesley Gorman, Nelia Leemans, Alice Lam, Travis Wood, Wilson Wong, Philip Lee, Tim Lu, Gary Lee
Journal: Blood
Blood (2021) 138 (Supplement 1): 2799.
https://doi.org/10.1182/blood-2021-154201
Published: 2021
Journal Articles

ZFP521 regulates murine hematopoietic stem cell function and facilitates MLL-AF9 leukemogenesis in mouse and human cells

Brief Report
Brian S. Garrison, Adrian P. Rybak, Isabel Beerman, Balthasar Heesters, Francois E. Mercier, David T. Scadden, David Bryder, Roland Baron, Derrick J. Rossi
Journal: Blood
Blood (2017) 130 (5): 619–624.
https://doi.org/10.1182/blood-2016-09-738591
Published: 2017
Includes: Supplemental data